Perceptions and Barriers to Human Papillomavirus Vaccination and Cervical Cancer Screenings: A Survey Study of Underserved Populations in North Texas
- PMID: 40496434
- PMCID: PMC12039564
- DOI: 10.1002/puh2.70018
Perceptions and Barriers to Human Papillomavirus Vaccination and Cervical Cancer Screenings: A Survey Study of Underserved Populations in North Texas
Abstract
Background: Human papillomavirus (HPV) is a common cause of cervical cancer along with several other neoplasms. With the availability of HPV vaccination and cervical cancer screenings, it is more likely for cervical cancers to be prevented or caught early in their course. However, there are disparities and barriers preventing all individuals from obtaining proper preventative care.
Methods: An online survey analyzing compliance, barriers, and subjective perceptions of HPV vaccination and cervical cancer screening was distributed via flyers. These were placed in the half of zip codes with lowest median income in Fort Worth, Texas.
Results: Respondents with non-White race, income of $40,000 or less, and a maximum education of high school or less were 4.24, 3.2, and 1.2 times more likely to have incomplete HPV vaccination, respectively. Respondents with an income of $40,000 or less and a maximum education of high school were 3.2 and 2.6 times more likely to be overdue for cervical cancer screening, respectively. The most common barrier for HPV vaccination was lack of knowledge, and for cervical cancer screening, it was cost. Most respondents felt as though cervical cancer screening allows for early cancer detection and decreased mortality but also endorsed feelings of pain, embarrassment, and fear of the test.
Conclusions: HPV vaccine and cervical cancer screening non-compliance is likely multifactorial, including lack of knowledge and cost. Interventions such as increased access to pediatric care and increased opportunities for free preventative healthcare may be helpful in both reducing stigma and improving access to care.
Keywords: Pap smear; barriers to care; barriers to healthcare; cervical cancer screening; human papillomavirus; human papillomavirus (HPV) vaccination; women's health.
© 2024 The Author(s). Public Health Challenges published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Centers for Disease Control and Prevention , Epidemiology and Prevention of Vaccine‐Preventable Diseases (Washington, DC: Public Health Foundation, 2021), https://www.cdc.gov/vaccines/pubs/pinkbook/index.html.
-
- World Health Organization , Human Papillomavirus Vaccines: WHO Position Paper, December, 2022. Weekly Epidemiological Record 50, no. 97 (2022): 645–672.
-
- Brisson M., Kim J. J., Canfell K., et al., “Impact of HPV Vaccination and Cervical Cancer Screening on Cervical Cancer Elimination: A Comparative Modelling Analysis in 78 Low‐Income and Lower‐Middle‐Income Countries,” Lancet 395, no. 10224 (2020): 575–590, doi: 10.1016/S0140-6736(20)30068-4. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials